The angel investing network Ark Angel Alliance announced that it has surpassed $500,000 in investments in Arkansas-affiliated startups since it launched in early 2020.
The group’s current portfolio of five companies includes the medical device companies SFC Fluidics of Fayetteville and Vascugenix of Little Rock, the targeted therapy and immune-oncology company MAIA Biotechnology, and Rogers-based industrial workspace provider Loloft.
Ark Angel Alliance, originally known as the Central Arkansas Angel Network, evaluates deals from across the nation but gives preference to Arkansas-affiliated deals. Thus far, it has only invested in Arkansas-affiliated companies.
“We are marking a great milestone in the genesis of angel investing in Arkansas,” Alese Stroud, chair of the Ark Angel Alliance Board of Directors, said in a news release. “The group is providing capital at a critical stage for entrepreneurs, but we’re also providing diversified investment opportunities for Arkansas investors.”
Grace Rains, executive director of Ark Angel Alliance, said the group is adding new investors and portfolio companies.
“We’re just getting started,” she said in the release.
Sign up for Daily E-news
